Inhibition of gp120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5'-phosphate

L. Guo, N. K. Heinzinger, M. Stevenson, L. M. Schopfer, J. M. Salhany

Research output: Contribution to journalComment/debate

10 Scopus citations


Pyridoxal 5'-phosphate and related compounds were tested for their ability to inhibit gp120-CD4 interaction and human immunodeficiency virus infection in vitro. The results show that pyridoxal 5'-phosphate is a unique CD4 antagonist whose antiviral potency derives from the presence of both lysine- reactive and anionic substituents.

Original languageEnglish (US)
Pages (from-to)2483-2487
Number of pages5
JournalAntimicrobial agents and chemotherapy
Issue number10
StatePublished - Jan 1 1994
Externally publishedYes


ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this